The effect of warfarin treatment on renal plasminogen activator inhibitor-1 and tissue factor gene expression in a rat model of type 2 diabetic nephropathy.

被引：0
|
作者：
Hagiwara, H
Li, W
Watanabe, K
Seki, T
Uriu, K
Takagi, I
Ling, QY
Ariga, T
Okada, K
Kaizu, K
机构：
[1] Nihon Univ, Grad Sch Appl Life Sci, Dept Nutr & Physiol, Fujisawa, Kanagawa, Japan
[2] Univ Occupat & Environm Hlth, Kidney Ctr, Kitakyushu, Fukuoka 807, Japan
[3] Nihon Univ, Sch Med, Dept Internal Med 2, Tokyo 173, Japan
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：391A / 391A
页数：1
相关论文
共 50 条
  • [1] Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy
    Xu, Fengbo
    Liu, Huilan
    Sun, Yi
    RENAL FAILURE, 2016, 38 (01) : 157 - 162
  • [2] The expression of tissue type plasminogen activator, plasminogen activator inhibitor-1, tissue factor and tissue factor pathway inhibitor mRNA by VEGF in rat aortic endothelial cell
    Sugano, T
    Tsuji, H
    Masuda, H
    Yoshizumi, M
    Kasahara, T
    Nishimura, H
    Nakahara, S
    Nakagawa, K
    Nakagawa, M
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS570 - PS570
  • [3] Effect of Tisseel® on expression of tissue plasminogen activator and plasminogen activator inhibitor-1
    Diamond, MP
    Kruger, M
    Saed, GM
    FERTILITY AND STERILITY, 2004, 81 (06) : 1657 - 1664
  • [4] The role of camp in the gene expression of plasminogen activator inhibitor-1 and tissue factor in adipocyte
    Hayashi, A.
    Ono, N.
    Tomita, A.
    Takeya, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 396 - 396
  • [5] Effect of dibutyryl cyclic adenosine monophosphate on the gene expression of plasminogen activator inhibitor-1 and tissue factor in adipocytes
    Taniguchi, Makoto
    Ono, Naoko
    Hayashi, Akira
    Yakura, Yuwna
    Takeya, Hiroyuki
    THROMBOSIS RESEARCH, 2011, 128 (04) : 375 - 380
  • [6] Role of oxidative stress in high glucose-induced plasminogen activator inhibitor-1 upregulation in diabetic nephropathy.
    Lee, EA
    Seo, J
    Seo, J
    Kwon, MK
    Ha, H
    Lee, HB
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 386A - 387A
  • [7] Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells
    Nishimura, H
    Tsuji, H
    Masuda, H
    Nakagawa, K
    Nakahara, Y
    Kitamura, H
    Kasahara, T
    Sugano, T
    Yoshizumi, M
    Sawada, S
    Nakagawa, M
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (06) : 1189 - 1195
  • [8] The Expression of Plasminogen Activator Inhibitor-1 was Associated with Neointimal Hyperplasia in the Type 2 Diabetic Rats
    Kwon, Jin Sook
    Ahn, Youngkeun
    Kim, Yong Sook
    Jeong, Myung Ho
    Cho, Jeong Gwan
    Park, Jong Chun
    Kang, Jung Chaee
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 178D - 179D
  • [9] THE EFFECT OF INSULIN-TREATMENT ON THE BALANCE BETWEEN TISSUE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN TYPE-2 DIABETIC-PATIENTS
    VUKOVICH, T
    PROIDL, S
    KNOBL, P
    TEUFELSBAUER, H
    SCHNACK, C
    SCHERNTHANER, G
    THROMBOSIS AND HAEMOSTASIS, 1992, 68 (03) : 253 - 256
  • [10] Effect of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms on Susceptibility to Type 2 Diabetes in Malaysian Subjects
    Al-Hamodi, Zaid
    Saif-Ali, Riyadh
    Ismail, Ikram S.
    Ahmed, Khaled A.
    Muniandy, Sekaran
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2012,
12345